GLENMARK PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Download	< Back
08 Jun 2021
Glenmark's interim data from PMS Study on Favipiravir (FabiFlu??) supports its safety and effectiveness in real world settings with no new safety signals or concerns in Covid-19<BR> patients
View all announcements for GLENMARK PHARMACEUTICALS LTD.	Source: BSE India

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us